Inclisiran in primary prevention : reality or fiction ?

Gencer, Baris; Mach, François

doi:10.1093/eurheartj/ehac653

Scientific article

Editorial

English

Inclisiran in primary prevention : reality or fiction ?

ContributorsGencer, Baris

; Mach, François

Published inEuropean heart journal, vol. 43, no. 48, p. 5058-5060

Publication date2022-12-21

Abstract

**This editorial refers to ‘Effect of inclisiran on lipids in primary prevention: the ORION-11 trial’, by K.K. Ray et al., https://doi.org/10.1093/eurheartj/ehac615**

Keywords

Humans
Anticholesteremic Agents
Cholesterol, LDL
RNA, Small Interfering

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Athérosclérose (591)

Citation (ISO format)

GENCER, Baris, MACH, François. Inclisiran in primary prevention : reality or fiction ? In: European heart journal, 2022, vol. 43, n° 48, p. 5058–5060. doi: 10.1093/eurheartj/ehac653

Article (Published version)

Identifiers

PID : unige:175240
DOI : 10.1093/eurheartj/ehac653
PMID : 36331327

Additional URL for this publicationhttps://academic.oup.com/eurheartj/article/43/48/5058/6795826?login=true

Journal ISSN0195-668X

135views

0downloads

Creation19/10/2023 14:14:23

First validation28/02/2024 16:04:52

Update21/01/2025 15:51:40

Status update21/01/2025 15:51:40

Last indexation10/06/2025 21:54:49

Archive ouverte UNIGE

Inclisiran in primary prevention : reality or fiction ?

This editorial refers to ‘Effect of inclisiran on lipids in primary prevention: the ORION-11 trial’, by K.K. Ray et al., https://doi.org/10.1093/eurheartj/ehac615

Technical informations

**This editorial refers to ‘Effect of inclisiran on lipids in primary prevention: the ORION-11 trial’, by K.K. Ray et al., https://doi.org/10.1093/eurheartj/ehac615**